Articles |
the Department of Physiology, Emory University School of Medicine, Atlanta, Ga.
Correspondence to Dr Peter L. Becker, Department of Physiology, Emory University School of Medicine, 1648 Pierce Dr, Atlanta, GA 30322. E-mail plb@physio.emory.edu.
| Abstract |
|---|
|
|
|---|
Key Words: ventricular myocyte cyclic ADP-ribose Ca2+-induced Ca2+ release
| Introduction |
|---|
|
|
|---|
Both cADPR and the enzymes for its synthesis and degradation appear to be ubiquitously distributed in a variety of tissues, including heart,12 13 14 supporting the hypothesis that cADPR may be an endogenous regulator of Ca2+ signaling in general. Nonetheless, the mechanism by which cADPR might mobilize Ca2+ is unclear, even in the better-characterized sea urchin egg system. The identity of cADPR-binding proteins has not been established,15 and cofactors (putative and identified) are probably necessary for its action.16 17 Given the uncertainty of whether conditions for cADPR action are preserved in cell-free systems, we decided to directly examine the ability of cADPR to regulate cardiac SR Ca2+ release in a more physiological intact ventricular myocyte preparation. Voltage-clamped myocytes were loaded with caged cADPR18 and a Ca2+-sensitive dye, and the effects of flash photolysis-induced change in cADPR concentration on SR Ca2+ release were then studied.
| Materials and Methods |
|---|
|
|
|---|
Freshly isolated myocytes were bathed in a solution containing (mmol/L) NaCl 115, CsCl 20, CaCl2 1.0, MgCl2 1.0, HEPES 10, and glucose 10 (pH 7.4 with NaOH). Myocytes were patch-clamped at room temperature (22°C to 24°C) under the ruptured-patch whole-cell configuration using 2- to 4-M
Corning 7052 electrodes filled with an intracellular pipette solution containing (mmol/L) cesium aspartate 120, CsCl 25, HEPES 5, tetraethylammonium chloride 5, NaCl 10, and Mg-ATP 3 (pH 7.2 with CsOH). Inward ICas were directly measured under voltage-clamp conditions with an AxoPatch-1D amplifier (Axon Instruments). Fast inward Na+ current was eliminated by holding resting membrane potential at -40 mV. Rapid brief pulses of caffeine were gently pressure-ejected onto the surface of a myocyte from a micropipette filled with 1 or 2.5 mmol/L caffeine. Conditioning depolarization pulses to 0 mV (0.5 Hz, 300-millisecond duration) were used to load the SR to a steady state before all tests of Ca2+ release.
The high time-resolution microfluorimeter consisted of a Zeiss IM-35 inverted microscope, a quartz objective (x100; numerical aperture, 1.20), a photomultiplier tube, and a three-segment filter wheel that allows sequential excitation at 340, 380, and 470 nm (
133 Hz). [Ca2+]i was monitored with 100 µmol/L fluo 3 (when using caged compounds) or fura 2. FI measurements made at 510 to 550 nm, when excited at 470 nm (fluo 3) or at 340 and 380 nm (fura 2), were corrected for background, and autofluorescence was measured before rupturing the patch. A xenon flashlamp (Hi-tech) that produces a burst of light
1 millisecond in duration was merged with the excitation light path of the microfluorimeter with a beam splitter. The flashlamp light was filtered through a UG5 filter. Control experiments have shown that a UV flash alone without caged compounds does not induce any changes in either fluorescence or whole-cell currents.
The egg microinjection procedure was modified from that described by Lee et al.2 Dejellied Lytechinus pictus eggs were placed in artificial sea water (mmol/L: NaCl 460, MgCl2 27, MgSO4 28, CaCl2 10, KCl 10, and NaHCO3 2.5 [pH 8.0 with NaOH]) at room temperature. Fluo 3 (5 mmol/L) and caged cADPR (500 µmol/L) were dissolved in a microinjection buffer (0.5 mol/L KCl, 50 µmol/L EGTA, and 10 mmol/L MOPS [pH 6.7 with KOH]) and pressure-injected (40 to 60 psi) into eggs. The amount of caged cADPR loading was assessed by estimating fluo 3 loading by the method of Moore et al.20 Briefly, the total cellular fluo 3 FI was recorded and compared with similar measurements derived from bubbles of a Ca2+-containing fluo 3 solution of known volume created by injection into hydrated oil. On the basis of these calculations, we estimate the maximum injected volume to have been no more than 3% to 5% of the egg volume; thus, the final egg caged cADPR concentrations were
15 to 25 µmol/L.
Sea urchins (Lytechinus pictus) were obtained from Marinus, Inc. Caged cADPR, nitrophenyl-EGTA, 8-amino-cADPR, fura 2, and fluo 3 were from Molecular Probes. Ryanodine was from Calbiochem-Novabiochem Corp. All other reagents were acquired from Sigma. All values reported in the text are mean±SEM. An unpaired Student's t test was used to assess group differences. A value of P<.01 was accepted as significant.
| Results |
|---|
|
|
|---|
3 seconds later. No change in the fluo 3 FI was observed. In 13 myocytes, the UV flash-induced FI change was 0.0±0.7%, compared with the 302±9% rise in response to depolarization to 0 mV. Identical results (data not shown) were obtained from myocytes loaded with either 100 µmol/L caged cADPR alone (without calmodulin) or with lower concentrations of caged cADPR (0.1 to 10.0 µmol/L). In contrast, extracellular application of caffeine from a micropipette located near the cell did trigger SR Ca2+ release (Fig 1B
120 nmol/L), a single UV flash could rapidly elevate [Ca2+]i, and this initial [Ca2+]i rise induced an additional rise due to CICR (Fig 1C
|
We next examined whether a step change in the cADPR concentration would alter the sensitivity of the SR Ca2+ release process to its physiological trigger, the voltage-dependent ICa. In preliminary experiments, flash photolysis of caged cADPR immediately before depolarization to 0 mV did not change the resulting intracellular Ca2+ transient amplitude (not shown). However, it is likely that the ICa elicited at 0 mV was already more than sufficient to trigger a maximal SR Ca2+ release. Therefore, further experiments were designed to ascertain whether photolytically generated cADPR could alter the magnitude of a submaximal SR Ca2+ release triggered by a smaller ICa.
Submaximal ICa levels were elicited by depolarization to less positive test potentials chosen so that the intracellular Ca2+ transient amplitude was approximately one third of its amplitude after depolarization to 0 mV. After a train of conditioning pulses to 0 mV, a single UV flash was triggered
100 milliseconds before the first depolarization to this test potential. As illustrated in Fig 2A
, photolysis of caged cADPR (right) did not change the amplitude of the subsequent intracellular Ca2+ transient relative to that observed in an identical control sequence (left). To quantify changes in the sensitivity of the SR to the trigger ICa, we have defined a gain factor as equal to the change in the fluorescence signal divided by the peak ICa magnitude (both normalized to their maximum values). As shown in Fig 2C
, this gain factor remained unchanged after photolysis of caged cADPR under these conditions (control, 7.1±0.7; flash, 7.3±0.7; P=.49, n=8). In contrast, ejection of 1 mmol/L caffeine near a fura 2-loaded myocyte that was repetitively depolarized to a submaximal test potential increased the intracellular Ca2+ transient amplitude, without increasing ICa (Fig 2B
). Consequently, the gain factor increased 43% (control, 5.8±0.7; flash, 8.0±0.5; P<.01, n=4). Note that the values of the gain factor under control conditions are different for the two treatments because a different Ca2+ dye was used. Thus, cADPR did not modulate the sensitivity of the SR Ca2+ release process to the trigger ICa, whereas caffeine did.
|
To verify that physiological amounts of cADPR were indeed generated inside cells, we examined the ability of our caged cADPR lot and photolysis system to induce Ca2+ release in sea urchin eggs taken from the sea urchin Lytechinus pictus. Caged cADPR and fluo 3 were microinjected into eggs. We estimated the final caged cADPR concentration to have been
15 to 25 µmol/L (see "Materials and Methods"). A single UV flash induced a large intracellular Ca2+ transient (Fig 3
). The average fluo 3 FI increase was 333±11%, and the average time to peak FI was 3.0±0.2 seconds (n=8 eggs). Despite the rapid jump in the cADPR concentration, in all cases the initial [Ca2+]i rose slowly, with a mean delay of 660±100 milliseconds before the onset of the rapid phase. These intracellular Ca2+ transients are comparable (although faster in onset and time to peak) to those triggered by direct injection of cADPR into the intact eggs.2 23 Thus, in sea urchin eggs loaded with caged cADPR, a single flashlamp burst was capable of producing a robust Ca2+ release.
|
Consequently, it seems reasonable to conclude that equivalent step changes in the cADPR concentration do not regulate SR Ca2+ release in cardiac myocytes. Nevertheless, our results to this point do not necessarily exclude cADPR as a modulator of cardiac SR Ca2+ release. Based on whole tissue assays, the endogenous level of cADPR in rat heart has been estimated to be
200 nmol/L,12 a value that, if all cytosolic, would be approximately threefold to fourfold greater than the ED50 for Ca2+ release in intact sea urchin eggs.23 In light of this, since we were unable to control the basal cADPR concentration, we cannot be certain that the flash-induced cADPR rise produced a physiologically relevant increase in the cADPR signal. Further, notwithstanding the positive response observed in sea urchin eggs, we cannot be certain that the kinetics or magnitude of cADPR transient, shaped by the myocyte's normal metabolic processes, would be appropriate for the cascade of events that might be required for cADPR modulation of Ca2+ release in heart. Given these uncertainties, our next approach was to determine if high levels of authentic cADPR or its antagonist, 8-amino-cADPR, would alter CICR when present intracellularly for a sustained period. We reasoned that if cADPR were a modulator of SR Ca2+ release in heart, at least one of these treatments should affect normal CICR, regardless of the basal conditions or the kinetics of the transduction pathway.
Myocytes were equilibrated with our standard electrode solution containing fura 2 (control) or with the addition of one of the following: 100 µmol/L cADPR, 10 µmol/L 8-amino-cADPR, or 30 µmol/L ryanodine. The cADPR concentration (>1000 times its ED50 in sea urchin eggs23 ) was chosen in an attempt to overwhelm the endogenous cADPR hydrolase, although we did not independently confirm this. 8-Amino-cADPR has been shown to be a potent competitive antagonist of cADPR-induced Ca2+ release in sea urchin egg extracts24 and in mammalian intestinal smooth muscle cells25 at submicromolar concentrations. A set of intracellular Ca2+ transients (as indicated by the fura 2 340/380 FI ratio) resulting from different ICa amplitudes were evoked by imposing 300-millisecond depolarization pulses to different potentials over a range of -30 to +10 mV. Fig 4A
shows the dependence of the intracellular Ca2+ transient amplitude on the ICa magnitude from these experiments. The data from each myocyte were normalized to their Imax and
[Ca2+]i values. Under control conditions, the
[Ca2+]i-ICa relation is hyperbolic. With ryanodine, the intracellular Ca2+ transient amplitude elicited by Imax decreased 69% (Fig 4B
), and the
[Ca2+]i-ICa relation was linear. These effects of ryanodine are an expected consequence of eliminating the SR contribution to the intracellular Ca2+ transient.26 In contrast, the
[Ca2+]i-ICa relations observed in myocytes loaded with cADPR or 8-amino-cADPR were indistinguishable from control (Fig 4A
). Neither cADPR nor 8-amino-cADPR affected the maximum [Ca2+]i change evoked by Imax (Fig 4B
), nor was the peak ICa observed at 0 mV altered (peak ICa was 1.41±0.10, 1.45±0.15, and 1.44±0.16 nA for control, cADPR, and 8-amino-cADPR, respectively; n=6 for each). Thus, intracellular application of supermaximal concentrations of either cADPR or 8-amino-cADPR did not alter the normal CICR, whereas ryanodine did.
|
| Discussion |
|---|
|
|
|---|
Both Lee et al16 and Tanaka et al17 have reported that submicromolar calmodulin is a required cofactor for cADPR Ca2+-releasing activity in sea urchin egg extracts. Despite the fact that endogenous levels of calmodulin are in the micromolar range in heart,27 we took the precaution of adding 0.6 µmol/L calmodulin in our patch pipette solution to guard against the unlikely possibility that endogenous calmodulin was depleted by intracellular dialysis.
Meszaros et al9 previously reported that submicromolar cADPR enhanced 45Ca2+ efflux from cardiac, but not skeletal muscle, SR preparations. This action was found to be Ca2+ dependent and blocked by ryanodine. cADPR also enhanced 3[H]ryanodine binding to cardiac SR and increased the open probability of single RyRCs being reconstituted in the planar lipid bilayers. These later findings suggested that the mechanism of cADPR's action on SR Ca2+ release was by modulation of the RyRC. However, the evidence supporting this direct modulation of the RyRC has been challenged. Under similar conditions, Fruen et al10 failed to replicate these findings. Sitsapesan and colleagues11 28 found that although cADPR could modulate cardiac (and skeletal muscle) RyRC gating in the presence of millimolar lumenal [Ca2+], this direct stimulatory effect on RyRC was observed only in the absence of cytosolic Mg-ATP (conditions similar to those used by Meszaros et al9 ). Since as little as 100 µmol/L Mg-ATP prevented cADPR activation of the RyRC, these authors proposed that cADPR may act by binding to a nucleotide binding site, but only under conditions of extreme ATP depletion. Thus, the mechanism by which cADPR could stimulate Ca2+ release in isolated SR vesicles remains controversial. Given the inability of cADPR to modulate Ca2+ release in our intact myocyte preparation, we are unable at this point to reconcile our findings with the SR Ca2+-releasing activity reported by Meszaros et al.
In summary, neither a step change in the cADPR concentration nor the sustained presence of cADPR or its antagonist 8-amino-cADPR modulated SR Ca2+ release in cardiac myocytes. In all cases, we have contrasted the inability of cADPR to modulate SR Ca2+ release in our preparation with evidence that under similar conditions agents known to modulate SR Ca2+ release (ie, Ca2+, caffeine, and ryanodine) were able to do so in a manner consistent with their known mechanisms of action. Therefore, we believe the most reasonable interpretation of our results is that cADPR does not regulate SR Ca2+ release in intact cardiac myocytes.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received April 30, 1996; accepted May 14, 1996.
| References |
|---|
|
|
|---|
2.
Lee HC, Aarhus R, Walseth TF. Calcium mobilization by dual receptors during fertilization of sea urchin eggs. Science. 1993;261:352-355.
3. White AM, Watson SP, Galione A. Cyclic ADP-ribose-induced Ca2+ release from rat brain microsomes. FEBS Lett. 1993;318:259-263.[Medline] [Order article via Infotrieve]
4.
Koshiyama H, Lee HC, Tashjian AH Jr. Novel mechanism of intracellular calcium release in pituitary cells. J Biol Chem. 1991;266:16985-16988.
5.
Takasawa S, Nata K, Yonekura H, Okamoto H. Cyclic ADP-ribose in insulin secretion from pancreatic beta cells. Science. 1993;259:370-373.
6.
Beers KW, Chini EN, Lee HC, Dousa TP. Metabolism of cyclic ADP-ribose in opossum kidney renal epithelial cells. Am J Physiol. 1995;268:C741-C746.
7. Currie KP, Swann K, Galione A, Scott RH. Activation of Ca2+-dependent currents in cultured rat dorsal root ganglion neurones by a sperm factor and cyclic ADP-ribose. Mol Biol Cell. 1992;3:1415-1425.[Abstract]
8. Hua SY, Tokimasa T, Takasawa S, Furuya Y, Nohmi M, Okamoto H, Kuba K. Cyclic ADP-ribose modulates Ca2+ release channels for activation by physiological Ca2+ entry in bullfrog sympathetic neurons. Neuron. 1994;12:1073-1079.[Medline] [Order article via Infotrieve]
9. Meszaros LG, Bak J, Chu A. Cyclic ADP-ribose as an endogenous regulator of the non-skeletal type ryanodine receptor Ca2+ channel. Nature. 1993;364:76-79.[Medline] [Order article via Infotrieve]
10. Fruen BR, Mickelson JR, Shomer NH, Velez P, Louis CF. Cyclic ADP-ribose does not affect cardiac or skeletal muscle ryanodine receptors. FEBS Lett. 1994;352:123-126.[Medline] [Order article via Infotrieve]
11.
Sitsapesan R, McGarry SJ, Williams AJ. Cyclic ADP-ribose competes with ATP for the adenine nucleotide binding site on the cardiac ryanodine receptor Ca2+-release channel. Circ Res. 1994;75:596-600.
12. Walseth TF, Aarhus R, Zeleznikar RJ Jr, Lee HC. Determination of endogenous levels of cyclic ADP-ribose in rat tissues. Biochim Biophys Acta. 1991;1094:113-120.[Medline] [Order article via Infotrieve]
13. Meszaros V, Socci R, Meszaros LG. The kinetics of cyclic ADP-ribose formation in heart muscle. Biochem Biophys Res Commun. 1995;210:452-456.[Medline] [Order article via Infotrieve]
14. Lee HC, Aarhus R. Wide distribution of an enzyme that catalyzes the hydrolysis of cyclic ADP-ribose. Biochim Biophys Acta. 1993;1164:68-74.[Medline] [Order article via Infotrieve]
15.
Walseth TF, Aarhus R, Kerr JA, Lee HC. Identification of cyclic ADP-ribose-binding proteins by photoaffinity labeling. J Biol Chem. 1993;268:26686-26691.
16. Lee HC, Aarhus R, Graeff R, Gurnack ME, Walseth TF. Cyclic ADP ribose activation of the ryanodine receptor is mediated by calmodulin. Nature. 1994;370:307-309.[Medline] [Order article via Infotrieve]
17.
Tanaka Y, Tashjian AH Jr. Calmodulin is a selective mediator of Ca2+-induced Ca2+ release via the ryanodine receptor-like Ca2+ channel triggered by cyclic ADP-ribose. Proc Natl Acad Sci U S A. 1995;92:3244-3248.
18.
Aarhus R, Gee K, Lee HC. Caged cyclic ADP-ribose: synthesis and use. J Biol Chem. 1995;270:7745-7749.
19. Mitra R, Morad M. A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates. Am J Physiol. 1985;249:H1056-H1060.
20. Moore ED, Becker PL, Fogarty KE, Williams DA, Fay FS. Ca2+ imaging in single living cells: theoretical and practical issues. Cell Calcium. 1990;11:157-179. Review.[Medline] [Order article via Infotrieve]
21.
O'Neill SC, Eisner DA. A mechanism for the effects of caffeine on Ca2+ release during diastole and systole in isolated rat ventricular myocytes. J Physiol (Lond). 1990;430:519-536.
22.
Ellis-Davies GC, Kaplan JH. Nitrophenyl-EGTA, a photolabile chelator that selectively binds Ca2+ with high affinity and releases it rapidly upon photolysis. Proc Natl Acad Sci U S A. 1994;91:187-191.
23. Dargie PJ, Agre MC, Lee HC. Comparison of Ca2+ mobilizing activities of cyclic ADP-ribose and inositol trisphosphate. Cell Regul. 1990;1:279-290.[Medline] [Order article via Infotrieve]
24. Walseth TF, Lee HC. Synthesis and characterization of antagonists of cyclic-ADP-ribose-induced Ca2+ release. Biochim Biophys Acta. 1993;1178:235-242.[Medline] [Order article via Infotrieve]
25.
Kuemmerle JF, Makhlouf GM. Agonist-stimulated cyclic ADP ribose: endogenous modulator of Ca2+-induced Ca2+ release in intestinal longitudinal muscle. J Biol Chem. 1995;270:25488-25494.
26.
Beuckelmann DJ, Wier WG. Mechanism of release of calcium from sarcoplasmic reticulum of guinea-pig cardiac cells. J Physiol (Lond). 1988;405:233-255.
27. Klee RS, Vanaman TC. Calmodulin. In: Advances in Protein Chemistry. New York, NY: Academic Press Inc; 1982;35:213-321.
28.
Sitsapesan R, Williams AJ. Cyclic ADP-ribose and related compounds activate sheep skeletal sarcoplasmic reticulum Ca2+ release channel. Am J Physiol. 1995;268:C1235-C1240.
This article has been cited by other articles:
![]() |
X. Zhang, Y. N. Tallini, Z. Chen, L. Gan, B. Wei, R. Doran, L. Miao, H.-B. Xin, M. I. Kotlikoff, and G. Ji Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not {beta}-adrenergic stimulation in mouse cardiomyocytes Cardiovasc Res, November 1, 2009; 84(2): 253 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Guse, X. Gu, L. Zhang, K. Weber, E. Kramer, Z. Yang, H. Jin, Q. Li, L. Carrier, and L. Zhang A Minimal Structural Analogue of Cyclic ADP-ribose: SYNTHESIS AND CALCIUM RELEASE ACTIVITY IN MAMMALIAN CELLS J. Biol. Chem., April 22, 2005; 280(16): 15952 - 15959. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamishima and J. M. Quayle P2 receptor-mediated Ca2+ transients in rat cerebral artery smooth muscle cells Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H535 - H544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Bradley, S. Currie, D. MacMillan, T. C. Muir, and J. G. McCarron Cyclic ADP-ribose increases Ca2+ removal in smooth muscle J. Cell Sci., November 1, 2003; 116(21): 4291 - 4306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fill and J. A. Copello Ryanodine Receptor Calcium Release Channels Physiol Rev, October 1, 2002; 82(4): 893 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Prakash, M. S. Kannan, T. F. Walseth, and G. C. Sieck cADP ribose and [Ca2+]i regulation in rat cardiac myocytes Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1482 - H1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Laflamme and P. L. Becker Gs and adenylyl cyclase in transverse tubules of heart: implications for cAMP-dependent signaling Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1841 - H1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Balligand Regulation of cardiac {beta}-adrenergic response by nitric oxide Cardiovasc Res, August 15, 1999; 43(3): 607 - 620. [Full Text] [PDF] |
||||
![]() |
A. J Lokuta, A. Darszon, C. Beltran, and H. H Valdivia Detection and functional characterization of ryanodine receptors from sea urchin eggs J. Physiol., July 1, 1998; 510(1): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.A Eisner, A.W Trafford, M.E Dnaz, C.L Overend, and S.C O'Neill The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation Cardiovasc Res, June 1, 1998; 38(3): 589 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Laflamme and P. L. Becker Do beta 2-adrenergic receptors modulate Ca2+ in adult rat ventricular myocytes? Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1308 - H1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-P Mothet, P Fossier, F-M Meunier, J Stinnakre, L Tauc, and G Baux Cyclic ADP-ribose and calcium-induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia J. Physiol., March 1, 1998; 507(2): 405 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.W Trafford, M.E Dieaz, and D.A Eisner Stimulation of Ca-induced Ca release only transiently increases the systolic Ca transient: measurements of Ca fluxes and sarcoplasmic reticulum Ca Cardiovasc Res, March 1, 1998; 37(3): 710 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iino, Y. Cui, A. Galione, and D. A. Terrar Actions of cADP-Ribose and Its Antagonists on Contraction in Guinea Pig Isolated Ventricular Myocytes : Influence of Temperature Circ. Res., November 19, 1997; 81(5): 879 - 884. [Abstract] [Full Text] |
||||
![]() |
X. Guo and P. L. Becker Cyclic ADP-ribose-gated Ca2+ Release in Sea Urchin Eggs Requires an Elevated [Ca2+] J. Biol. Chem., July 4, 1997; 272(27): 16984 - 16989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Sutko, J. A. Airey, W. Welch, and L. Ruest The Pharmacology of Ryanodine and Related Compounds Pharmacol. Rev., March 1, 1997; 49(1): 53 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Vatner, B. C. Berk, L. A. Leinwand, P. Libby, K. Schwartz, and H. C. Strauss A Second Term for the Editors: Status and Goals for the Review Process Circ. Res., July 1, 1996; 79(1): 1 - 3. [Full Text] |
||||
![]() |
V. Lukyanenko, I. Gyorke, T. F. Wiesner, and S. Gyorke Potentiation of Ca2+ Release by cADP-Ribose in the Heart Is Mediated by Enhanced SR Ca2+ Uptake Into the Sarcoplasmic Reticulum Circ. Res., September 28, 2001; 89(7): 614 - 622. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |